ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1063
https://www.valueinhealthjournal.com/article/S1098-3015(16)01131-1/fulltext
Title :
ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01131-1&doi=10.1016/j.jval.2016.03.1063
First page :
A248
Section Title :
Systemic Disorders/Conditions - Cost Studies
Open access? :
No
Section Order :
911